west virginia glp-1 diarrhea law firm patients are left in limbo over changing insurance coverage of obesity medications semaglutide gastrointestinal obstruction law firm

We adhere to treatments and protocols that are backed by robust clinical evidence and approved by medical authorities

January 2026: Amgen completed Phase 3 enrollment for MariTide (AMG 133) in the MARITIME-Obesity trial, with interim efficacy data expected in Q3 2026 that will position the monthly injection GLP-1/GIP antagonist as a once-monthly obesity treatment alternative

High Triglycerides: Triglyceride levels equal to or greater than 150 mg/dL

List prices run $969 to $1,069 monthly, but real cash prices have dropped through manufacturer direct programs and TrumpRx pricing, with some brand options now in the $350 to $500 range